Equity Capital Markets

Company · CIK 1907108

Lexeo Therapeutics, Inc.

CIK1907108 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Business addressNY
ListedLXEO (Nasdaq)
First annual or quarterly report2023-12-11

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-291269
ShelfEffective
 2025-11-052025-11-262
333-283781
ShelfEffective
 2024-12-132025-10-175
333-288025
ShelfEffective
 2025-06-132025-06-302
333-278566
Registered companyEffective
 2024-04-092024-12-033
333-274777
IPOFinal prospectus
 2023-09-292023-11-065

Filings

18
FiledFilingRegistrationAccession
2025-11-26EFFECTDeclared effective 333-2912699999999995-25-003406
2025-11-05S-3Shelf registered 333-2912690001193125-25-265934
2025-10-17424B5Shelf takedown 333-2837810001193125-25-242649
2025-10-16424B5Shelf takedown 333-2837810001193125-25-241560
2025-06-30EFFECTDeclared effective 333-2880259999999995-25-002095
2025-06-13S-3Shelf registered 333-2880250001193125-25-140744
2025-03-24424B5Shelf takedown 333-2837810001193125-25-060883
2024-12-19EFFECTDeclared effective 333-2837819999999995-24-003844
2024-12-13S-3Shelf registered 333-2837810001193125-24-277929
2024-12-03EFFECTDeclared effective 333-2785669999999995-24-003642
2024-04-12EFFECTDeclared effective 333-2785669999999995-24-000964
2024-04-09S-1Registration filed 333-2785660001193125-24-090233
2023-11-06424B4Final prospectus 333-2747770001193125-23-271432
2023-11-02EFFECTDeclared effective 333-2747779999999995-23-003175
2023-11-01S-1/AAmendment 333-2747770001193125-23-268301
2023-10-30S-1/AAmendment 333-2747770001193125-23-265646
2023-09-29S-1Registration filed 333-2747770001193125-23-247367
2022-02-04DRSDraft made public 377-059850000950123-22-001044

All filings of this company · CSV